Pharmacotherapy of Chagas Disease

Breakout Session
Main Building ED 213
P, AAFP, DO, PA, NP, N, D, PH

Pharmacotherapy of Chagas Disease
There are an estimated 8 million people in the world who have Chagas disease with an estimated mortality of 10,000 deaths per year. This session will briefly review the epidemiology, symptoms and characteristics of Chagas disease and then focus in on the pharmacotherapy options available for Chagas disease both within the United States and around the world. We will then move on to challenges associated with Chagas disease, such as co-infection with HIV and conclude with a look at the ongoing research and future therapies for the disease.

Objectives

Review the symptoms of Chagas disease
Create a pharmacotherapeutic plan for a patient with Chagas disease
Discuss the current state of research and development for new therapies for Chagas disease